Tag: Epclusa

Gilead Sciences bags Epclusa FDA approval for hepatitis C in pediatric patients

pharmanewsdaily- March 20, 2020

Epclusa FDA approval : Gilead Sciences has secured an expanded approval for Epclusa (sofosbuvir 400mg/velpatasvir 100mg; sofosbuvir 200mg/velpatasvir 50 mg) from the US Food and ... Read More